In the fall of 2018, MedShadow Foundation and three past FDA executives contributed an amici curiae brief to the Supreme Court in the case of Merck vs. Albrecht.
The Supreme Court heard the case on Monday, January 7, 2019. The ruling is expected to be published in May.
Did Merck Circumvent Its Duty To Warn on ‘Fosamax Fractures’?
MedShadow Blog: What’s Next for the Fosamax Case in the Supreme Court?